219 related articles for article (PubMed ID: 18205042)
1. 25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture.
Peng X; Hawthorne M; Vaishnav A; St-Arnaud R; Mehta RG
Breast Cancer Res Treat; 2009 Jan; 113(1):31-41. PubMed ID: 18205042
[TBL] [Abstract][Full Text] [Related]
2. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.
Mehta RG; Moriarty RM; Mehta RR; Penmasta R; Lazzaro G; Constantinou A; Guo L
J Natl Cancer Inst; 1997 Feb; 89(3):212-8. PubMed ID: 9017001
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of mammary carcinogenesis by 1alpha-hydroxyvitamin D5, a synthetic analog of Vitamin D.
Mehta RG; Hussain EA; Mehta RR; Das Gupta TK
Mutat Res; 2003; 523-524():253-64. PubMed ID: 12628523
[TBL] [Abstract][Full Text] [Related]
4. Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D-3, the major circulating form of vitamin D-3.
Kemmis CM; Salvador SM; Smith KM; Welsh J
J Nutr; 2006 Apr; 136(4):887-92. PubMed ID: 16549446
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of chemopreventive agents in mouse mammary gland organ culture (MMOC) model: a comprehensive review.
Mehta RG; Naithani R; Huma L; Hawthorne M; Moriarty RM; McCormick DL; Steele VE; Kopelovich L
Curr Med Chem; 2008; 15(27):2785-825. PubMed ID: 18991637
[TBL] [Abstract][Full Text] [Related]
6. A 24-phenylsulfone analog of vitamin D inhibits 1alpha,25-dihydroxyvitamin D(3) degradation in vitamin D metabolism-competent cells.
Lechner D; Manhardt T; Bajna E; Posner GH; Cross HS
J Pharmacol Exp Ther; 2007 Mar; 320(3):1119-26. PubMed ID: 17182978
[TBL] [Abstract][Full Text] [Related]
7. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
8. Stage-specific inhibition of mammary carcinogenesis by 1alpha-hydroxyvitamin D5.
Mehta RG
Eur J Cancer; 2004 Oct; 40(15):2331-7. PubMed ID: 15454260
[TBL] [Abstract][Full Text] [Related]
9. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.
Segersten U; Holm PK; Björklund P; Hessman O; Nordgren H; Binderup L; Akerström G; Hellman P; Westin G
Breast Cancer Res; 2005; 7(6):R980-6. PubMed ID: 16280049
[TBL] [Abstract][Full Text] [Related]
10. Tumoral Vitamin D Synthesis by CYP27B1 1-α-Hydroxylase Delays Mammary Tumor Progression in the PyMT-MMTV Mouse Model and Its Action Involves NF-κB Modulation.
Li J; Luco AL; Ochietti B; Fadhil I; Camirand A; Reinhardt TA; St-Arnaud R; Muller W; Kremer R
Endocrinology; 2016 Jun; 157(6):2204-16. PubMed ID: 27119753
[TBL] [Abstract][Full Text] [Related]
11. Autocrine metabolism of vitamin D in normal and malignant breast tissue.
Townsend K; Banwell CM; Guy M; Colston KW; Mansi JL; Stewart PM; Campbell MJ; Hewison M
Clin Cancer Res; 2005 May; 11(9):3579-86. PubMed ID: 15867263
[TBL] [Abstract][Full Text] [Related]
12. Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels.
Anderson PH; O'Loughlin PD; May BK; Morris HA
Bone; 2005 Apr; 36(4):654-62. PubMed ID: 15781002
[TBL] [Abstract][Full Text] [Related]
13. Quantification of mRNA for the vitamin D metabolizing enzymes CYP27B1 and CYP24 and vitamin D receptor in kidney using real-time reverse transcriptase- polymerase chain reaction.
Anderson PH; O'Loughlin PD; May BK; Morris HA
J Mol Endocrinol; 2003 Aug; 31(1):123-32. PubMed ID: 12914530
[TBL] [Abstract][Full Text] [Related]
14. Colon-specific regulation of vitamin D hydroxylases--a possible approach for tumor prevention.
Kállay E; Bises G; Bajna E; Bieglmayer C; Gerdenitsch W; Steffan I; Kato S; Armbrecht HJ; Cross HS
Carcinogenesis; 2005 Sep; 26(9):1581-9. PubMed ID: 15905206
[TBL] [Abstract][Full Text] [Related]
15. 25-hydroxyvitamin D3 is an active hormone in human primary prostatic stromal cells.
Lou YR; Laaksi I; Syvälä H; Bläuer M; Tammela TL; Ylikomi T; Tuohimaa P
FASEB J; 2004 Feb; 18(2):332-4. PubMed ID: 14657005
[TBL] [Abstract][Full Text] [Related]
16. Calcitriol regulates the expression of the genes encoding the three key vitamin D3 hydroxylases and the drug-metabolizing enzyme CYP3A4 in the human fetal intestine.
Theodoropoulos C; Demers C; Delvin E; Ménard D; Gascon-Barré M
Clin Endocrinol (Oxf); 2003 Apr; 58(4):489-99. PubMed ID: 12641633
[TBL] [Abstract][Full Text] [Related]
17. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
[TBL] [Abstract][Full Text] [Related]
18. Hormonal regulation of 25-hydroxyvitamin D3-1alpha-hydroxylase and 24-hydroxylase gene transcription in opossum kidney cells.
Armbrecht HJ; Hodam TL; Boltz MA
Arch Biochem Biophys; 2003 Jan; 409(2):298-304. PubMed ID: 12504896
[TBL] [Abstract][Full Text] [Related]
19. 25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of 1alpha-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer.
de Lyra EC; da Silva IA; Katayama ML; Brentani MM; Nonogaki S; Góes JC; Folgueira MA
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):184-92. PubMed ID: 16828283
[TBL] [Abstract][Full Text] [Related]
20. 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells.
Ritter CS; Armbrecht HJ; Slatopolsky E; Brown AJ
Kidney Int; 2006 Aug; 70(4):654-9. PubMed ID: 16807549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]